| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue |
-
| 12 | | Cost of Revenue |
-
|
-
| | | Gross Profit |
-
| 12 | | | Operating Expenses | | Research Development | 993 | 758 | | Selling General and Administrative | 2,433 | 3,065 | | Non Recurring |
-
|
-
| | Others | 41 | 43 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (3,467) | (3,854) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | (3,467) | (3,854) | | Interest Expense | 3,260 | 2,214 | | Income Before Tax | (6,727) | (6,068) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (6,727) | (6,068) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (6,727) | (6,068) | | Preferred Stock And Other Adjustments | (1,782) |
-
| | | Net Income Applicable To Common Shares | ($8,509) | ($6,068) |
|
0.47% Nasdaq 
Income Statement
